![Steven N. Chatfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven N. Chatfield
Direttore/Membro del Consiglio presso
Cell Therapy Catapult Ltd.
Profilo
Steven N.
Chatfield is currently a Non-Executive Director at Cell Therapy Catapult Ltd. and a Director at Prokarium Ltd. and Prokarium Holdings Ltd. He is also a Non-Executive Director at Vaccitech (UK) Ltd. Previously, Dr. Chatfield held positions as the Chief Scientific Officer & Development Director at Microscience Ltd. from 1999 to 2004.
He was also a Director at Wellcome Foundation Ltd. and served as the Director at the Health Protection Agency in 2009.
Additionally, he was the President of Bio Defense Corp in 2010 and the Executive VP-Strategic Investment Division at Emergent BioSolutions, Inc. from 2013 to 2014.
He also served as the President & Chief Scientific Officer at Emergent Product Development UK Ltd. from 2005 to 2007.
Dr. Chatfield obtained a doctorate degree from the University of Birmingham.
Posizioni attive di Steven N. Chatfield
| Società | Posizione | Inizio |
|---|---|---|
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Engages in development of cell and gene therapy | Direttore/Membro del Consiglio | 07/03/2016 |
Prokarium Ltd.
 Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Develops vaccination solutions | Direttore/Membro del Consiglio | 05/10/2021 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Direttore/Membro del Consiglio | - |
Prokarium Holdings Ltd.
 Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management services | Direttore/Membro del Consiglio | 05/10/2021 |
Precedenti posizioni note di Steven N. Chatfield
| Società | Posizione | Fine |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 31/03/2014 |
Bio Defense Corp
 Bio Defense Corp Chemicals: SpecialtyProcess Industries Develops bio-chemical defense products used as disinfectants for mail ordered food products | Presidente | 01/03/2010 |
Health Protection Agency
 Health Protection Agency General GovernmentGovernment Governmental department | Direttore/Membro del Consiglio | 01/01/2009 |
Emergent Product Development UK Ltd.
 Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Presidente | 31/08/2007 |
Microscience Ltd.
 Microscience Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Steven N. Chatfield
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
52
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Microscience Ltd.
Microscience Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax | Health Technology |
Wellcome Foundation Ltd
 Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Commercial Services |
Bio Defense Corp
Bio Defense Corp Chemicals: SpecialtyProcess Industries Develops bio-chemical defense products used as disinfectants for mail ordered food products | Process Industries |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Health Protection Agency
Health Protection Agency General GovernmentGovernment Governmental department | Government |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Health Technology |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Engages in development of cell and gene therapy | Health Technology |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Develops vaccination solutions | Commercial Services |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management services | Commercial Services |
